A significant advance in cancer investigation is arising with the use of nanobodies to re-engage damaged p53. This essential malignant inhibitor protein is frequently inactivated in many types of malignancies, https://thesocialvibes.com/story7536065/mini-antibodies-revive-p53-a-new-approach-for-malignant-therapy